Enterprise Financial Services Corp Horizon Therapeutics Public LTD CO Transaction History

Enterprise Financial Services Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $300,410 - $365,485	-3,048 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $273,707 - $328,681	2,978 Added 4254.29%	3,048 $334,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $2,414 - $2,685	28 Added 66.67%	70 $7,000
Q1 2021 May 13, 2021	BUY	$71.83 - $95.48 $2,226 - $2,959	31 Added 281.82%	42 $4,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $737 - $928	11 New	11 $1,000
Q2 2020 Aug 04, 2020	SELL	$30.2 - $56.98 $875 - $1,652	-29 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$24.87 - $38.56 $721 - $1,118	29 New	29 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.